The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.

PRIORITY PRESS - 26th International Papillomavirus Conference and Clinical and Public Health Workshops

Enhanced Treatment Strategies for External Genital Warts

Montreal, Quebec / July 3-8, 2010

It is estimated that approximately 75% to 80% of sexually active men and women have been exposed to genital human papillomavirus (HPV). Types 6 and 11 are the cause of most cases of genital warts (GW) worldwide (J Am Osteopath Assoc...

PRIORITY PRESS - 105th Annual Meeting of the American Urological Association

GnRH Antagonists: Advances in Androgen Deprivation Therapy for Prostate Cancer

San Francisco, California / May 29-June 3, 2010

San Francisco - GnRH agonists effectively suppress testosterone in over 90% of patients with advanced prostate cancer but can require as much as 30 days to achieve full suppressive effects, during which time testosterone levels actually...

PRIORITY PRESS - 25th Congress of the European Association of Urology

Androgen Deprivation Therapy in Prostate Cancer

Barcelona, Spain / April 16-20, 2010

Barcelona - New data have reinforced the utility of a gonadotropin-releasing hormone (GnRH) receptor blocker for slowing progression of advanced prostate cancer. Following a previous phase III study in which this agent compared favourably...

PRIORITY PRESS - 3rd World Congress on Controversies in Urology

An Enhanced Medical Approach to Androgen Suppression in Prostate Cancer

Athens, Greece / February 25-28, 2010

Athens - It has been 70 years since investigators first understood that prostate cancer is hormone-sensitive and that medical suppression of testosterone production can control the tumour and affect long-term disease outcomes. Yet there are...

PRIORITY PRESS - EUROGIN 2010 9th International Multidisciplinary Congress

Vaccination Against HPV Reduces Burden of Disease in Its Earliest Manifestations

Monte Carlo, Monaco / February 17-20, 2010

Monte Carlo - Many theoretical arguments have been raised in support of vaccination against human papillomavirus (HPV). Now, for the first time, compelling evidence that vaccination does reduce the earliest manifestations of infection in...

PRIORITY PRESS - Society of Urologic Surgeons of Ontario Meeting

Improving Survival in Prostate Cancer Through Enhanced Androgen Suppression

Toronto, Ontario / October 21, 2009

Toronto - Therapeutic options for the treatment of prostate cancer continue to expand, from orchiectomy, the first effective treatment, through to a variety of formulations of gonadotropin-releasing hormone (GnRH) agonists and now, more...

MEDICAL FRONTIERS - 64th Annual Meeting of the Canadian Urological Association

Prostate Cancer Risk Reduction with 5-alpha Reductase Inhibitors

Toronto, Ontario / June 28-July 1, 2009

Toronto - Research efforts continue to examine the possible role of risk reduction initiatives in prostate cancer and there have been several important new developments in the field. For example, recent analyses of the initial PCPT...

PRIORITY PRESS - Primary Care Today

Outgrowing Old Attitudes and Approaches to Nocturnal Enuresis

Toronto, Ontario / May 7-9, 2009

Toronto - Nocturnal enuresis is the frequent involuntary discharge of urine during sleep in children who have reached an age at which bladder control is expected. It is a condition that frustrates parents and can engender low self-esteem...

PRIORITY PRESS - 104th Annual Meeting of the American Urological Society

Relearning and Refining the Lessons from the Prostate Cancer Prevention Trial

Chicago, Illinois / April 25-30, 2009

Chicago - Few clinical trials have met with such diverse reactions as those that followed the findings of the PCPT (Prostate Cancer Prevention Trial). The trial represented an unprecedented triumph in cancer prevention, demonstrating a 25%...

PRIORITY PRESS - 104th Annual Meeting of the American Urological Association

Androgen Deprivation Therapy for Prostate Cancer: From Hormonal Agonism to Antagonism

Chicago, Illinois / April 25-30, 2009

Chicago - Androgen deprivation therapy (ADT) has become an integral component of treatment for many patients with hormone-sensitive advanced prostate cancer. Multiple studies have shown that ADT blunts the progression of prostate cancer,...

PAGE 3 OF 8   1 2 3 4 5 6 7 8